Ross Greenwood speaks to the CEO of Noxopharm, Dr Graham Kelly about the formation of a new biotechnology company with a view to tackling the problem of cancer drug resistance
Ross Greenwood speaks to former Treasurer and Current Future Fund Chairman, Peter Costello about the challenging global market and why governments are "running out of shots" to protect against any future financial shocks.